Financial Performance - Consolidated revenues for fiscal year 2023 reached $822.4 million, a 56% increase from $527.2 million in fiscal year 2022[221] - Net income for fiscal year 2023 was $(22.9) million, a decline of 147% compared to $48.3 million in fiscal year 2022[221] - Total revenue for the fiscal year ended May 31, 2023, was $822.4 million, a 56% increase from $527.2 million in the prior fiscal year[240] - Operating income decreased to $37.5 million, representing 4.6% of sales, down from $58.6 million and 11.1% in the prior year[245] - The net loss for fiscal year 2023 was $22.9 million, resulting in a net income margin of -2.8%, compared to a net income of $48.3 million and a margin of 9.2% in fiscal year 2022[259] - For the fiscal year 2023, Neogen reported an Adjusted EBITDA of $205.4 million, an increase of $90.1 million compared to $115.4 million in fiscal year 2022, with an Adjusted EBITDA margin of 25.0%[261] Revenue Segments - Food Safety segment revenues were $546.8 million, up 110% from $260.0 million, with core sales growth of 6%[221] - International revenues increased by 90% to $398.4 million, driven by 3M FSD, which contributed $279.5 million since its acquisition[222] - Service revenue grew by 5% to $107.4 million, primarily due to increased demand in the U.S. beef and companion animal markets[227] - Core sales growth for the Animal Safety segment was 2%, with revenues of $275.7 million, a slight increase from $267.2 million[221] - Food Safety segment revenues increased significantly, with Culture Media & Other growing by 255% and Bacterial & General Sanitation by 185% compared to the previous year[230][231] Expenses and Costs - Operating expenses rose to $368.4 million, a 100% increase from $184.4 million in the prior fiscal year, largely due to costs associated with the 3M FSD transaction[241] - Research and development expenses increased by 53% to $26.0 million, driven by ongoing costs related to the integration of 3M FSD employees[244] - Interest income rose to $3.2 million, while interest expense was $56.0 million, reflecting the debt incurred for the 3M FSD transaction[247] - Net loss for fiscal year 2023 was $22.9 million, compared to net income of $48.3 million in the previous year, primarily due to $56 million in interest expense from debt incurred for the 3M FSD transaction[250] Tax and Financial Position - The effective tax rate decreased to (3.8)% in fiscal year 2023 from 19.8% in the previous year[221] - Unrecognized tax benefits increased to $1.1 million as of May 31, 2023, primarily due to the 3M FSD acquisition[249] - Cash generated from operating activities decreased to $41.0 million in fiscal year 2023 from $68.0 million in fiscal year 2022, primarily due to 3M FSD transaction costs[266] - As of May 31, 2023, Neogen's cash, cash equivalents, and marketable securities totaled $245.6 million[266] - Neogen's long-term debt obligations total $900 million, with interest obligations of $351.6 million due over various periods[275] Strategic Initiatives - The acquisition of 3M's food safety division was completed for approximately $3.2 billion, resulting in customer relationships intangible assets valued at $1.17 billion[212] - The company plans to invest approximately $120 million over the next two fiscal years to construct a new manufacturing facility in Lansing, Michigan[276] - The merger with 3M's Food Safety business was completed on September 1, 2022, significantly impacting Neogen's financial metrics and operational strategies[270] Risks and Future Outlook - The company expects inflation and geopolitical tensions to continue impacting operations throughout fiscal year 2024[202] - Foreign exchange risk exposure affects revenues and expenses due to transactions in currencies other than the U.S. dollar[279] - A 10% decrease in exchange rates could lead to a potential loss of $39,844,000 in future earnings from foreign currency revenue[280] - A 10% decrease in exchange rates may result in a fair value impact of $1,550,000 from foreign currency hedges[280] - A 10% decrease in interest rates could decrease interest income by $434,000[280] - A 10% increase in interest rates may increase interest expense by $2,125,000[280] Goodwill and Impairment - The company recorded no impairment for goodwill during the annual analysis in fiscal year 2023, as the fair value of reporting units exceeded their carrying values[218] - The company recorded a loss of $1.5 million on the dissolution of its minority interest in Corvium, Inc. following its acquisition in February 2023[247]
Neogen(NEOG) - 2023 Q4 - Annual Report